04 July 2024
04 July 2024
Upon completion of the deal, LifeLabs will retain its headquarters, brand, and management team.
The initial redundancies are set to begin in March 2025, with the remaining job cuts planned by September 2026.
The trial found that the company’s AI platform saw success over the industry standard GPT-4 when it came to selecting patients for clinical trials.
The device aims to close the internal opening of the fistula tract and prevent recurrence.
The upgrades include new Smart Room Options for the ImageView Software and additional features for the DRX-Evolution Plus system.
The company’s published study shows that its AI-powered Enlight-DP platform can predict cancer treatment response from histopathology slides.
Avicenna.AI’s tools, which use AI to screen severe conditions from medical images, have been certified as Class IIb medical devices.
Politan Capital called for two of its nominees to be taken onto the company’s board amid concerns over the company’s performance as Masimo says it stands strong.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
